Global Insulin Market Expected to Reach USD 32,346.7 Million in 2018, with China Alone Accounting for 10.2%: Transparency Market Research

Informations

• Publié par: transparency-market-research
• Nombre de lectures: 15
• Langue: English

Extrait

Global Insulin Market Expected to Reach USD 32,346.7 Million in 2018, with China Alone Accounting for 10.2%: Transparency Market Research

PR Newswire ALBANY, New York, September 19, 2012

ALBANY, New York,September 19, 2012/PRNewswire/ -- According to a new market report published by Transparency Market Research (http://www.transparencymarketresearch.com) "Insulin Market-Global and China Scenario, Trends, Industry Analysis, Size, Share and Forecast, 2011-2018" the global insulin market was worthUSD 12,476.3 millionin 2011 and is expected to reachUSD 32,346.7 millionin 2018, growing at a CAGR of 12% from 2011 to 2018. In the global market,Chinais expected to increase its share in the global insulin market to 10.2% by 2018. Browse the full report athttp://www.transparencymarketresearch.com/http://www.transparencymarketresearch.com/insulin- market.html The global insulin market is driven by rise in diabetic population worldwide. The world diabetes population was estimated at 366 million in the year 2011, and is expected to reach 552 million in 2030. It is estimated that diabetes accounts for 4.6 million deaths, with cases of people dying due to lack of insulin and not even being diagnosed. This however, presents a huge supply demand deficit for insulin, with high growth potential in developing markets. The factors contributing to the insulin market growth also includes increase in global expenditure on healthcare, strong distribution network, and high scope in developing economies such asChinaandIndia. It is estimated that worldwide, by year 2030, one in ten people will suffer from diabetes, giving rise to huge demand for insulin.China, being the most populous nation in the world, accounts for the largest share of the global diabetic population and eventually turns out as the most lucrative market for insulin manufacturers. The China insulin market is projected to grow at a CAGR twice that of the global insulin market. It was estimated atUSD 723.8 millionin 2011, and is projected to reachUSD 3,299.1 millionin the year 2018, growing at a CAGR of 24.6%. Currently,Chinaaccounts for 6.1% of the global insulin market in terms of volume, which was estimated at 22.4 tMU in 2011. The global insulin market by volume is projected to grow at a CAGR of 7.9% from 2012 - 2018. The global insulin market has continuously witnessed new advanced product types being introduced in the market by insulin manufacturers. The recent product type is modern insulin, which is a genetically engineered version of human insulin, and has been selectively modified to counter the issues associated with human insulin. Currently, modern insulin accounts for more than 76% of the global insulin market.

Related & Recently Published Reports by Transparency Market Research

Minimally Invasive Surgery Market Global Osteoporosis Market Global Nutraceuticals Product Market Global Nutraceuticals Ingredients Market surgical equipment market size Asthma Drugs Industry Global Spectrometry Market Chromatography Market Trends Tablet Market Global Ophthalmology Devices Industry To meet the rising demand, global insulin manufacturers are not only augmenting existing production facilities, but also expanding their global presence to meet the supply demand gap. Leading insulin manufacturers are now focusing on reinforcing their market leadership inChina. It includes key

global andChinainsulin market players such as Novo Nordisk, Sanofi-Aventis, and Eli-Lilly. Together they account for more than 90% of the global insulin market share. This research is specially designed to estimate and analyze the demand and performance of the global andChinainsulin market in the current market scenario. This research provides in-depth analysis of insulin manufacturers, product sales, trend analysis by segments, and demand by geography. The report covers all the major product segments of the global andChinainsulin market and provides in-depth analysis, historical data and statistically refined forecast for the segments covered. The study presents a comprehensive assessment of the stakeholder strategies and winning imperatives for them by segmenting the global andChinainsulin market as below: By Action

Short Acting Pre-mixes Long Acting

By Type

Modern Human Animal

By Purchase Type

Dosage Bulk

Browse all PharmaceuticalMarketResearch Reports Upcoming Reports inPharmaceuticalMarket Cancer Biomarkers Market Health And Wellness Market Biotechnology Market Non Small Cell Lung Cancer Market Healthcare Equipment Market Genitourinary Drugs Market The Role of IT and Telecom in Healthcare Industry Medical Education Market Biomarkers Market Colorectal Cancer Market About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Sheela AK 90 Sate Street, Suite 700 Albany, NY12207 Tel: [phone] USA- Canada Toll Free: [phone]

Email:[e-mail]